soccer online betting,sportsbook pa,super etv telugu show,andar game Group Overview
- The Healthcare Group
-
Stories
-
![]()
'Diversity is enrichment'
-
![]()
Saving lives – with and beyond dialysis
-
![]()
Doubling up on a second chance
-
![]()
A robot at the operating table
-
![]()
Midwife, a dream job
-
![]()
My 50 years of dialysis
-
![]()
Living life to the fullest with dialysis
-
![]()
Growing up with parenteral nutrition
-
![]()
The History of Dialysis
-
![]()
Serving patients in Swaziland
-
![]()
"I want to help others, so they won’t give up"
-
![]()
From a local pharmacy to a global corporation
-
'Diversity is enrichment'
Saving lives – with and beyond dialysis
Doubling up on a second chance
A robot at the operating table
Midwife, a dream job
My 50 years of dialysis
Living life to the fullest with dialysis
Growing up with parenteral nutrition
The History of Dialysis
Serving patients in Swaziland
"I want to help others, so they won’t give up"
From a local pharmacy to a global corporation-
Highlights
- Capital Markets Day
- Share
- Investor News
- Strategy & Outlook
- Events & Roadshows
- Financial Reports & Presentations
- Financial Results
- Ad-hoc News
- Group Figures
-
Annual General Meeting
- Credit Relations
- FAQ
- Contacts
Investor Relations & Sustainability
+49 (0) 6172 608-2485
ir-fre@fresenius.com
Senior Vice President Corporate Communications
T: +49 (0) 6172 608-2872
matthias.link@fresenius.com
Corporate Communications
Here you can find a variety of information:
- Press releases and Brief news
- Key dates for journalists
- Pictures, videos, audio files, press kits and other documents
- Social media channels
- Personal contacts
Our Corporate Communications team can be reached at pr-fre@fresenius.com.
-
-
LATEST
andar game Kabi closed the acquisition announced in March of Ivenix, Inc. (“Ivenix”), a specialized infusion therapy company. Ivenix adds a next-generation infusion therapy platform for the significant U.S. market to andar game Kabi’s portfolio and provides the company with key capabilities in hospital connectivity. The combination of Ivenix’s leading hardware and software products with andar game Kabi’s offering in intravenous fluids and infusion devices will create a comprehensive and leading portfolio of premium products, forming a strong basis to enable sustainable growth in the high-value MedTech space. The purchase price is a combination of US$240 million upfront payment and milestone payments, strictly linked to the achievement of commercial and operating targets.
free-penny-slots-online
andar game Kabi and the U.S. based company Cerus Corporation signed a new agreement for the production of systems for pathogen inactivation in blood components. The collaboration will help expanding access to pathogen-reduced blood components to patients. For many years, Cerus and andar game Kabi have collaborated regarding medical products specializing in pathogen inactivation for platelets and plasma. Since market launch of Cerus’ INTERCEPT systems, more than 11 million units have been in use worldwide.
bet364Calcium Gluconate in Sodium Chloride Injection is now available in ready-to-administer non-DEHP, non-PVC containers, complementing the company’s existing vial presentations in the United States. andar game Kabi now has the broadest portfolio of Calcium Gluconate in Sodium Chloride Injection products available from any manufacturer in the United States.
pirates-of-the-caribbean-telugu-dubbed-movie-watch-online
The European Commission (EC) has granted andar game Kabi the marketing authorization for Stimufend®, the company’s pegfilgrastim biosimilar, for all approved indications of the reference medicine. Stimufend® stimulates the growth of certain white blood cells, which are essential to prevent or fight infections, a common life-threatening risk in patients receiving myelosuppressive chemotherapy. This is the company’s first approved biosimilar molecule used in oncology and its second biosimilar approved in Europe, expanding its autoimmune disease and oncology focused product portfolio.
casumo-money-train
andar game Kabi announced today that it has received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its wireless Agilia® Connect Infusion System which includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant® Software Suite-Vigilant Master Med technology. Both pumps are the first to be cleared by following TIR101 standards, which were developed by the Association for the Advancement of Medical Instrumentation (AAMI) in 2021. The product offering for hospitals and clinics enables the centralized distribution of drug libraries, warehousing of infusion data for reporting and analysis, and wireless maintenance and calibration of devices. The clearance is an important milestone for the company’s infusion therapy business in the U.S.
download-cristiano-ronaldo
